Schwarz Coping With Omeprazole Competition; Parcopa Is Next Launch
Schwarz' levodopa/carbidopa rapid dissolve formulation Parcopa will be the company's first attempt to convert its omeprazole windfall into a larger presence in the U.S. market
You may also be interested in...
Schwarz Pharma is responding to competition in the generic omeprazole market by offering retroactive discounts to wholesalers on its generic version of AstraZeneca's Prilosec
Novartis' Lek generic division is following Mylan with an "at risk" launch of generic omeprazole
Mylan's decision to launch the second generic version of AstraZeneca's Prilosec (omeprazole) could inject a new level of price competition into the proton pump inhibitor category